Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -4 of 4 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:

Last Modified: 10/17/2008 First Published: 11/22/2006


1.		Phase III Randomized Study of Augmented Berlin-Frankfurt-Münster-86 Multiagent Chemotherapy, Intensified Methotrexate, and Nelarabine in Younger Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				1 to 30				NCI				COG-AALL0434 AALL0434, NCT00408005


2.		Hyper-CVAD Plus Nelarabine in Untreated T-ALL/Lymphoblastic Lymphoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				Not specified				Other				2006-0328 NCT00501826


3.		506U78 In Relapsed Or Refractory Acute Lymphoblastic Leukemia (T-ALL)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				18 and over				Other				LN_GMALLE_2004_55 NCT00684619


4.		Clinical Evaluation of Nelarabine (506U78)in Japanese Patients With Leukemia or Lymphoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Biomarker/Laboratory analysis, Treatment				Active				Under 64				Pharmaceutical / Industry				PGA105446 NCT00406757

Select All on One Page

| | | | | | | |

A Service of the National Cancer Institute